Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Blood|July 29, 2010
Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)Sylvain Thepot, Raphael Itzykson, Valerie Seegers, et al.
Leukemia|July 16, 2020
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AMLAlix Dubois, Nathan Furstoss, Anne Calleja, et al.
Leukemia & Lymphoma|November 28, 2024
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemiaNicholas J Short, Agnieszka Wierzbowska, Thomas Cluzeau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia StudyJonathan Bond, Carlos Graux, Ludovic Lhermitte, et al.
Leukemia|January 5, 2019
LAMP2 expression dictates azacytidine response and prognosis in MDS/AMLAlix Dubois, Nathan Furstoss, Anne Calleja, et al.
Annals of Hematology|May 22, 2019
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)Jérôme Cornillon, Elisabeth Daguenet, Jacques-Olivier Bay, et al.
Blood Advances|April 8, 2025
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase Ib CIMON trialFlorent Malard, Sylvain Thepot, Thomas Cluzeau, et al.
Acta Haematologica|June 15, 2026
Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter studyEdmond Chiche, Caroline Fileni, Sarah Bonnet, et al.
Ejhaem|May 19, 2023
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotypeMar Mallo, Heinz Tuechler, Leonor Arenillas, et al.
Annals of Hematology|January 25, 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective studyLudovic Gabellier, Pierre Peterlin, Sylvain Thepot, et al.
Pageof 13